Genetic Analysis of Pediatric Gliomas |
Baylor College of Medicine / Will Parsons, MD, PhD |
'A' Award Grants |
2009 |
Texas |
Role of H3.3-G34R mutation in pediatric high-grade glioma |
University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD |
Innovation Grants |
2021 |
Texas |
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD |
Young Investigator Grants |
2023 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity |
University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD |
Innovation Grants |
2018 |
Texas |
Building a Texas-based center for neuroblastoma clinical research.
|
Baylor College of Medicine / Heidi Russell, MD |
Phase I/II Infrastructure Grants |
2006 |
Texas |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |